Cell Processing Instruments Market Report 2025

The cell processing instruments market size has grown strongly in recent years. It will grow from $6.43 billion in 2024 to $6.95 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to the increasing need for standardized cell processing protocols, the rising emphasis on personalized medicine, a greater number of regulatory approvals for cell therapy products, the growth of clinical trials involving cell-based treatments, and the expansion of biobank and cell repository infrastructure.

The cell processing instruments market size is expected to see strong growth in the next few years. It will grow to $9.39 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the increasing integration of automation in cell therapy manufacturing, the rising demand for scalable cell processing solutions, the growth in clinical trials for gene and cell therapies, higher investments in advanced bioprocessing technologies, and the growing need for good manufacturing practice (GMP)-compliant instrumentation. Key trends expected during this period include advancements in closed-system automation, the development of artificial intelligence (AI)-driven cell analysis tools, innovations in microfluidic cell sorting, progress in integrated quality control (QC) instrumentation, and the emergence of modular bioprocessing platforms.

The increasing investment in biopharmaceutical research is expected to drive the growth of the cell processing instruments market in the coming years. Biopharmaceutical research involves the study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. This rising investment is fueled by the growing demand for innovative therapies to address the increasing prevalence of chronic diseases and unmet medical needs, leading to greater research and development in targeted, effective treatments. Cell processing instruments play a key role by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For example, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, reported that 50 pharmaceutical companies invested \$167 billion in research and development in 2022. Therefore, the increasing investment in biopharmaceutical research is boosting demand for cell processing instruments.

Companies in the cell processing instruments market are focusing on technological innovations such as multi-channel asynchronous processing to improve workflow efficiency and flexibility in cell therapy development. Multi-channel asynchronous processing allows systems to run multiple independent workflows simultaneously on separate channels, enabling parallel operations without waiting for one another to finish. For instance, in June 2023, Singleron Biotechnologies GmbH, a Germany-based biotechnology company, introduced two new instruments, Python Junior and Matrix NEO, to enhance and standardize single-cell analysis workflows. Python Junior facilitates the dissociation of solid tissues into high-quality single-cell suspensions using dual independent channels and a combination of mechanical and enzymatic processing. Matrix NEO enables high-throughput, fully automated single-cell library preparation with chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, supporting a wide range of research and clinical applications.

In February 2023, Cytek Biosciences, a US-based life sciences company, acquired the flow cytometry imaging business from DiaSorin for an undisclosed amount. This acquisition was aimed at expanding Cytek’s global presence and strengthening its advanced cell analysis portfolio by integrating Luminex’s Flow Cytometry and Imaging business unit, including its technologies, expertise, and established customer network. DiaSorin S.p.A. is an Italy-based company that manufactures cell processing instruments.

Major players in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., and InGeneron Inc.

North America was the largest region in the cell processing instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell processing instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cell processing instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Cell processing instruments are specialized equipment designed for the precise handling of cells in both laboratory and production settings. They are developed to ensure accuracy, sterility, and consistency, supporting the preparation and manipulation of cells under standardized conditions. Equipped with advanced features, these instruments provide high performance, reliability, and compliance with safety and regulatory requirements.

The primary types of cell processing instruments include cell counters, cell imaging systems, flow cytometers, cell separator systems, automated cell processing systems, and others. Cell counters are devices specifically used to measure the number of cells in a sample quickly and accurately. These instruments are applied in processes such as cell isolation or separation, cell imaging and counting, cell viability and proliferation studies, and more. They serve a wide range of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs) and contract manufacturing organizations (CMOs), academic and research institutes, and others.

The cell processing instruments market research report is one of a series of new reports that provides cell processing instruments market statistics, including cell processing instruments industry global market size, regional shares, competitors with a cell processing instruments market share, detailed cell processing instruments market segments, market trends and opportunities, and any further data you may need to thrive in the cell processing instruments industry. This cell processing instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell processing instruments market consists of sales of centrifuges, microfluidic cell processors, single-use tubing and connectors, sterile filling, and sealing equipment. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.